Thrombosis
News
FDA limits use of J&J COVID vaccine over blood clot risk
“We recognize that the Janssen COVID-19 vaccine still has a role in the current pandemic response in the United States and across the global...
From the Journals
Traumatic brain injury linked to ‘striking’ risk for CVD, diabetes, brain disorders
Mild and moderate-to-severe TBI is linked to an increased risk for hypertension, stroke, diabetes, as well as neurological and psychiatric...
Conference Coverage
Anticoagulation not routinely needed after TAVR: ADAPT-TAVR
The ADAPT-TAVR trial showed a numerical reduction in leaflet thrombosis with edoxaban versus dual-antiplatelet therapy, but no reduction in...
From the Journals
Silver lining emerges for embolic protection in post-TAVR stroke
A database study found that embolic protection during transcatheter aortic valve replacement may improve outcomes, although not the occurrence, of...
News
FDA approves first drug for myelofibrosis with thrombocytopenia
Treatment option is the first for patients who have myelofibrosis with low platelet counts.
From the Journals
Post–COVID vaccine AHA cases raise eyebrows in Italy
Four cases of acquired hemophilia A that occurred following COVID-19 vaccinations in one Italian province could indicate “possible complications...
From the Journals
Rate of venous thromboembolism in hospitalized children continues to rise
“The risk of VTE is spread throughout all age groups, but consistent with prior findings, it is the highest in infants and adolescents.”
Conference Coverage
New hemophilia treatments: ‘Our cup runneth over’
A range of new options is emerging to treat hemophilia patients.
Conference Coverage
New stroke risk score developed for COVID patients
The user-friendly score represents a step forward but also points to the need to better risk-stratify patients for this complex, expensive, and...
Feature
Novel drug targets raised Lp(a): topline results released
Significant reductions in lipoprotein(a) were sustained out to 150 days in patients without cardiovascular disease in top-line phase 1 results...
From the Journals
Seniors face higher risk of other medical conditions after COVID-19
The risk of a new condition being triggered by COVID is more than twice as high in seniors, compared with younger patients, new research suggests...